Poster presentationsPD10 Photosensitivity diseases in children: 10 years’ experience from a tertiary photodiagnostic service
Jessica McKeever,Andrea Lesar,Sally H Ibbotson
DOI: https://doi.org/10.1093/bjd/ljae090.174
IF: 11.113
2024-06-28
British Journal of Dermatology
Abstract:Abstract Photosensitivity diseases are a wide-ranging group of disorders, with heterogeneity in diagnostic categories, characteristics and management. Photosensitivity at any age poses specific challenges, with adverse impact on quality of life being highly significant, and children are of particular concern (Rizwan M, Heylett AK, Richards HL et al. Impact of photosensitivity disorders on the life quality of children. Photoderm Photoimmunol Photomed 2012; 28: 290–2). Our aim was to review the clinical and photodiagnostic characteristics of 209 children (aged ≤ 16 years), assessed through a tertiary photodiagnostic service between 2013 and 2023. We conducted this retrospective study with Caldicott Guardian approval (CALDICOTT-2023-011) and the presenter, a final-year medical student, analysed clinical photodermatology notes and our in-house photodiagnostic database with support from senior clinical supervisors. The median age of presentation was 8 years (range 4 months to 16 years), with a male-to-female ratio of 1 : 1.2. Most patients were of skin phototype II (40.6%), with only five being phototype IV and two phototype V. The median time from onset of symptoms to assessment was 3 years (range 1 month to 14 years). Polymorphic light eruption (PLE) was the most prevalent condition, diagnosed in 50.4%. A range of other diagnoses were seen, with photosensitivity excluded in 7.3%. Of those who underwent monochromator phototesting (n = 180), abnormal results were detected in 29 patients (16.1%), and 27 of 128 patients (21.1%) tested had an abnormal ultraviolet B TL-01 minimal erythema dose. Of 128 patients who were photopatch tested, 27 (21.1%) showed positive reactions. Vitamin D levels were insufficient in eight (24%) of the 33 patients tested. Paediatric antinuclear antibodies were tested in 29% of patients, with 11 (18%) being positive (≥ 1 : 80), although lupus was diagnosed in only two cases. Of 109 patients tested for porphyria, 11 (10.1%) were positive, seven being diagnosed with erythropoietic protoporphyria. One patient was diagnosed with xeroderma pigmentosum (XP). Children’s Dermatology Life Quality Index (CLDQI) assessment was available in 69%, with a median score of 10 (range 1–29). This study provides detailed characterization of photosensitivity diseases in children seen through a national photodiagnostic service. While PLE was the most common diagnosis, a range of other diagnoses were seen, including lupus, porphyrias and XP, highlighting the need for such specialist services. The delays in diagnosis and severity of impact on quality of life are of concern and emphasize the importance of raising awareness of photosensitivity in children in primary care. Prompt diagnosis, psychological support and holistic care are identified aspects of service provision.
dermatology